Health Technology Assessment
Health Technology Assessment (HTA) is a kind of research that generates insights about the clinical- and cost-effectiveness of health technologies application in pharmaceutical and bio-pharmaceutical industries.
HTA is a process that involves information on medical, social, economic, and ethical issues in relation to the use of health technology in a systematic, transparent, unbiased and robust manner.
HTA is the process of systematically reviewing existing evidence on pharmaceutical and medical technology and health interventions and providing an evaluation of their safety, effectiveness, cost-effectiveness and impact on the health system.
Diagnostic and treatment methods, medical equipment, pharmaceuticals, rehabilitation & prevention methods, but also organizational and support systems used to deliver healthcare are examples of Health Technologies.
• What is the optimal pricing for your new product?
• How is your brand faring in the marketplace?
• How does the HTA work and the benefits to the companies?
• What are the unmet market needs?
• Which features in the new product are most important?
• How to optimize my product reimbursement scenario?
• How is the brand faring in the market (relative to competition)?
• What is the optimal price for my product on the basis of innovation and imitation?
How We Help?
• A review of clinical guidelines or HTA submissions in a particular therapeutic area
• Internal decision making on HTA strategy and positioning
• As a comparator and benchmark for non-HTA submissions
• HTA guidance should also recognize that patient preferences and responses to medicines vary, so patients should have access to a variety of therapeutic agents for a given condition.
• Our domain experts use extensive industry knowledge, market-leading expertise and vast experience across developed and emerging markets to provide detailed understanding on the entire HTA scena
• Technology Oriented Assessment: Technology Oriented Assessment is intended to determine the characteristics or impacts of particular technologies. For example, a pharmaceutical company may want to determine the clinical, economic, social, professional, or industrial impacts of population-based cancer screening, cochlear implants, or other particular interventions.
• Problem Oriented Assessments: Focus on solutions or strategies for managing a particular problem for which alternative or complementary technologies might be used. For example, clinicians and providers concerned with the problem of diagnosis of dementia may call for the development of clinical practice guidelines involving some combination or sequence of clinical history, neurological examination, and diagnostic imaging using various modalities.
• Project Oriented Assessments: Focus on a local placement or use of a technology in a particular institution, program, or other designated project. For example, this may arise when a hospital must decide whether or not to purchase a pharmaceutical product, considering the facilities, personnel, and other resources needed to install and operate an MRI unit; the hospital's financial status; local market potential for MRI services; competitive factors; etc.
• Health care safer by relying on scientific evidence and a committee of practicing clinicians
• Coverage decisions of state agencies more consistent
• State purchased health care more cost effective by paying for medical tools and procedures that are proven to work
• Coverage decision process more open and inclusive by sharing information, holding public meetings, and publishing decision criteria and outcomes.
• Health care payers, and employers about whether technologies should be included in health benefits plans or disease management programs, addressing coverage (whether or not to pay) and reimbursement (how much to pay)
• Clinicians and patients about the appropriate use of health care interventions for a particular patient’s clinical needs and circumstances
• Health professional associations about the role of a technology in clinical protocols or practice guidelines.